Nanavati Super Speciality Hospital Launches New Treatment for Parkinson’s in India
by Shrutee K/DNS
Mumbai, 5th December 2018 - Parkinson’s disease is one of
the common neurodegenerative disease affecting the people over the age of 55
years. Parkinson’s is characterized by slowness, stiffness and tremors is a
special neurodegenerative disorder with very few therapeutic options available.
In India, the prevalence of this disease advances between the age of 70-79. It
is caused by dopamine deficiency which is a chemical neuro transmitter in the
brain mainly in the centers controlling the mobility. Nanavati Super Speciality Hospital in association with Kings College, London have launched
the revolutionary treatment that will change the way Parkinson’s has been
treated in India. Apomorphine Pen
& Pump, the treatment that will radically change the life of a Parkinson’s
patient will now be available in India. The treatment was launched by our Chief
Guest – Honorable Health Minister of
Maharashtra -Dr. Deepak Sawant and Guest
of Honour – Padmashri. Paresh Rawal, Actor and M.P
Apomorphine is a highly selective Dopamine receptor stimulator, which
promotes the release of dopamine in the brain from the nerve cells, that is
otherwise absent. Dr. Rajendra Patankar,
COO, Nanavati Super Speciality Hospital speaking on the launch of the
radical treatment of Parkison’s says, “Apomorphine is a revolutionary
breakthrough to treat the Parkinson’s patients. Associating with the
prestigious King’s College, London has been an honor for us. As a healthcare
provider, we would like to commit ourselves to improve the healthcare in India
and bring in such great advancements in the field on medicine to India.”
The pen and pump treatment is an effective alternative for those who do
not want to undergo DBS. According to Dr.
Neeta Shah, Consultant Parkinson’s Disease and Movement Disorders Specialist, Nanavati
Super Specialty Hospital, Mumbai, “Parkinson’s disease in advance stage is
a challenge to treat. Patient suffer from progression in symptoms and side
effects of increasing dosages of standard medications. We need some novel way
to treat this. This treatment will be a boon for such patients. ”
Speaking about the launch, Dr. Vinod
Metta, Movement Disorders Specialist from London, UK, who is leading one of
biggest set of patients on Apomorphine in United Kingdom, told that Apomorphine
pens work dramatically with giving benefits to patients within couple of
minutes and are very similar to usage that of Insulin Pens.
You must be doing great service to ward off this disease suffering for mankind in our nation.Is the treatment through Pen and drive is financially affordable to our common people.Will you kindly oblige by replying to this for awareness of Parkinson patients.
ReplyDeletePlease send me contact numbers and mail IDs for further information, My brother Rakesh Saxena residing at Ahmedabad suffering Parkinson deseas since 15years, please do the needful
ReplyDeleteThank you for sharing such a useful blog with us. keep sharing.
ReplyDeleteParkinson's Disease Treatment in UAE
This comment has been removed by the author.
ReplyDelete